The comparison of long-term outcomes of mastoscopic and conventional axillary lymph node dissection in breast cancer: a multicenter randomized control trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001477

Enrollment

Unknown

Registered

2011-08-14

Start date

2003-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

MALND:Mastoscopic axillary lymph node dissection

CALND:Conventional lymph node dissection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the lymph nodes in axilla were negative or less than 1cm by clinical examination or color-ultrasonic inspection.

Exclusion criteria

Exclusion criteria: history of another cancer; preexisting limb disease causing swelling; previous surgery in iplateral axilla

Design outcomes

Primary

Measure	Time frame
disease-free survival and overall survival;	—

Secondary

Measure	Time frame
the operative effect indices of MALND comparing with CALND;	—

Countries

China

Contacts

Public ContactChengyu Luo

luochengyu@163.com+86 010 88062188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026